Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Dukart, Juergen ^a   Mueller, Karsten ^a   Horstmann, Annette ^a   Barthel, Henryk ^b   Möller, Harald E ^a   Villringer, Arno ^a,b   Sabri, Osama ^b   Schroeter, Matthias L ^a,b  

^a MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIORAL SCIENCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE PROCESSING; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; ALGORITHM; DIFFERENTIAL DIAGNOSIS; EVALUATION; MIDDLE AGED; SCINTISCANNING;

ALGORITHMS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 79952917724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018111     Document Type: Article

References (43)

1. Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, et al. (2000) FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 41: 1920-1928.
2. Rosen HJ, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, et al. (2002) Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58: 198-208.
3. Diehl J, Grimmer T, Drzezga A, Riemenschneider M, Forstl H, et al. (2004) Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging 25: 1051-1056.
4. Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, et al. (2005) 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 46: 233-239.
5. Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, et al. (2007) Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 28: 42-50.
6. Fung G, Stoeckel J, (2007) SVM feature selection for classification of SPECT images of Alzheimer's disease using spatial information. Knowledge and Information Systems 11: 243-258.
7. Sabri O, Kendziorra K, Wolf H, Gertz HJ, Brust P, (2008) Acetylcholine receptors in dementia and mild cognitive impairment. Eur J Nucl Med Mol Imaging 35 (Suppl 1): S30-45.
8. Schroeter ML, Raczka K, Neumann J, Yves von Cramon D, (2007) Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects. Neuroimage 36: 497-510.
9. Schroeter ML, Stein T, Maslowski N, Neumann J, (2009) Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 47: 1196-1206.
10. Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, et al. (2008) Automatic classification of MR scans in Alzheimer's disease. Brain 131: 681-689.
11. Matsunari I, Samuraki M, Chen WP, Yanase D, Takeda N, et al. (2007) Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance. J Nucl Med 48: 1961-1970.
12. Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM, (2008) Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage 41: 1220-1227.
13. Fan Y, Resnick SM, Wu X, Davatzikos C, (2008) Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage 41: 277-285.
14. Sadeghi N, Foster NL, Wang AY, Minoshima S, Lieberman AP, et al. (2008) Automatic classification of Alzheimer's disease vs. Frontotemporal dementia: A spatial decision tree approach with FDG-PET. 2008 Ieee International Symposium on Biomedical Imaging: From Nano to Macro Vols 1-4: 408-411.
15. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, et al. (2005) Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 57: 480-488.
16. Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, et al. (2002) Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology 58: 1801-1808.
17. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, et al. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-746.
18. Kipps CM, Hodges JR, Fryer TD, Nestor PJ, (2009) Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. Brain 132: 2566-2578.
19. Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, et al. (2001) Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 42: 548-557.
20. Ishii K, Sasaki H, Kono AK, Miyamoto N, Fukuda T, et al. (2005) Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging 32: 959-963.
21. Kanda T, Ishii K, Uemura T, Miyamoto N, Yoshikawa T, et al. (2008) Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging 35: 2227-2234.
22. van de Pol LA, Hensel A, van der Flier WM, Visser PJ, Pijnenburg YA, et al. (2006) Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry 77: 439-442.
23. Schroeter ML, Raczka K, Neumann J, von Cramon DY, (2008) Neural networks in frontotemporal dementia- -a meta-analysis. Neurobiol Aging 29: 418-426.
24. Chaves R, Ramirez J, Gorriz JM, Lopez M, Salas-Gonzalez D, et al. (2009) SVM-based computer-aided diagnosis of the Alzheimer's disease using t-test NMSE feature selection with feature correlation weighting. Neurosci Lett 461: 293-297.
25. Horn JF, Habert MO, Kas A, Malek Z, Maksud P, et al. (2009) Differential automatic diagnosis between Alzheimer's disease and frontotemporal dementia based on perfusion SPECT images. Artif Intell Med 47: 147-158.
26. Ramirez J, Gorriz JM, Salas-Gonzales D, Romero A, Lopez M, et al. (2009) Computer-aided diagnosis of Alzheimer's type dementia combining support vector machines and discriminant set of features. Information Sciences: doi:10.1016/j.ins.2009.05.012.
27. Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, et al. (2007) Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 22: 474-488.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
29. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554.
30. Chang CC, Lin CJ, (2001) LIBSVM: a library for support vector machines. Software available at:http://www.csie.ntu.edu.tw/~cjlin/libsvm.
31. Ashburner J, Friston KJ, (2005) Unified segmentation. Neuroimage 26: 839-851.
32. Ashburner J, (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38: 95-113.
33. Muller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, et al. (1992) Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 12: 571-583.
34. Rousset OG, Ma Y, Evans AC, (1998) Correction for partial volume effects in PET: principle and validation. J Nucl Med 39: 904-911.
35. Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, et al. (2004) Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 45: 192-201.
36. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, et al. (1997) Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 38: 925-928.
37. Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, et al. (2008) Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 164: 143-153.
38. Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, et al. (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44: 43-50.
39. Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, et al. (2010) Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 49: 1490-1495.
40. Morris JC, (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43: 2412-2414.
41. Folstein MF, Folstein SE, McHugh PR, (1975) Mini-Mental State (a practical method for grading the state of patients for the clinician). Journal of Psychiatric Research 12: 189-198.
42. Meguro K, Ishii H, Yamaguchi S, Ishizaki J, Sato M, et al. (2004) Prevalence and cognitive performances of clinical dementia rating 0.5 and mild cognitive impairment in Japan. The Tajiri project. Alzheimer disease and associated disorders 18: 3-10.
43. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, et al. (2006) Mapping scores onto stages: mini-mental state examination and clinical dementia rating. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry 14: 139-144.